The U.S. FDA has extended the commenting
period relating to supply chain
elements of the Drug Supply Chain Security
Act (DSCSA). The Agency is requesting
comments on product identifiers for
product tracing, supply chain technical
capabilities, and identification of system
attributes needed under the DSCSA.
Comments now close April 30, 2018.